_id
691b083a3c536f8df231895c
Ticker
ABLD.PA
Name
AbL Diagnostics SA
Exchange
PA
Address
72c, rue de Thionville, Woippy, France, 57140
Country
France
Sector
Healthcare
Industry
Health Information Services
Currency
EUR
Website
https://www.abldiagnostics.com
Description
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Last Close
3.1
Volume
41
Current Price
3.74
Change
-0.6451612903225812
Last Updated
2025-12-30T12:32:21.076Z
Image
https://logo.clearbit.com/www.abldiagnostics.com
Ipo Date
-
Market Cap
49843056
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
2599080
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-147930
Interest Expense
-
Pretax Income
-160210
Net Income
174690
Eps
0.010854436593288877
Dividends Per Share
-
Shares Outstanding
16078405
Income Tax Expense
-
EBITDA
-
Operating Margin
-5.6916293457685025
Total Other Income Expense Net
-
Cash
468780
Short Term Investments
60541
Receivables
3232110
Inventories
699420
Total Current Assets
8427230
Property Plant Equipment
463379
Total Assets
11809800
Payables
1402295
Short Term Debt
630
Long Term Debt
1521430
Total Liabilities
4323140
Equity
7486650
Bs_currency_symbol
EUR
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
103.3333
PB
8.039792323669465
ROE
2.3333533689968142
ROA
1.4791952446273433
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
48
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
2599080
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-147930
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-160210
Quarters > 0 > income Statement > net Income
174690
Quarters > 0 > income Statement > eps
0.010854436593288877
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16093880
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-5.6916293457685025
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
468780
Quarters > 0 > balance Sheet > short Term Investments
60541
Quarters > 0 > balance Sheet > receivables
3232110
Quarters > 0 > balance Sheet > inventories
699420
Quarters > 0 > balance Sheet > total Current Assets
8427230
Quarters > 0 > balance Sheet > property Plant Equipment
463379
Quarters > 0 > balance Sheet > total Assets
11809800
Quarters > 0 > balance Sheet > payables
1402295
Quarters > 0 > balance Sheet > short Term Debt
630
Quarters > 0 > balance Sheet > long Term Debt
1521430
Quarters > 0 > balance Sheet > total Liabilities
4323140
Quarters > 0 > balance Sheet > equity
7486650
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.010854436593288877
Quarters > 0 > ratios > PB
8.039792323669465
Quarters > 0 > ratios > ROE
2.3333533689968142
Quarters > 0 > ratios > ROA
1.4791952446273433
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
2731290
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-283200
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-276770
Quarters > 1 > income Statement > net Income
110490
Quarters > 1 > income Statement > eps
0.00686336383717261
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16098520
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-10.368726865327373
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
1670360
Quarters > 1 > balance Sheet > short Term Investments
18577
Quarters > 1 > balance Sheet > receivables
3022800
Quarters > 1 > balance Sheet > inventories
700710
Quarters > 1 > balance Sheet > total Current Assets
10227080
Quarters > 1 > balance Sheet > property Plant Equipment
463788
Quarters > 1 > balance Sheet > total Assets
13573310
Quarters > 1 > balance Sheet > payables
2356996
Quarters > 1 > balance Sheet > short Term Debt
10750
Quarters > 1 > balance Sheet > long Term Debt
1757680
Quarters > 1 > balance Sheet > total Liabilities
6724600
Quarters > 1 > balance Sheet > equity
6848710
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
110490
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
186830
Quarters > 1 > cash Flow > cash From Operations
253240
Quarters > 1 > cash Flow > capital Expenditures
447090
Quarters > 1 > cash Flow > cash From Investing
-409640
Quarters > 1 > cash Flow > cash From Financing
-379690
Quarters > 1 > cash Flow > net Change In Cash
-536080
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
0.00686336383717261
Quarters > 1 > ratios > PB
8.791212476510175
Quarters > 1 > ratios > ROE
1.6132965186144543
Quarters > 1 > ratios > ROA
0.8140239926738577
Quarters > 1 > ratios > FCF
-193850
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
-0.07097378894222144
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
3170520
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-175330
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-166380
Quarters > 2 > income Statement > net Income
74170
Quarters > 2 > income Statement > eps
0.004605716627649203
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16103900
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-5.5300076958984645
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
2224930
Quarters > 2 > balance Sheet > short Term Investments
94
Quarters > 2 > balance Sheet > receivables
3971610
Quarters > 2 > balance Sheet > inventories
707380
Quarters > 2 > balance Sheet > total Current Assets
11609060
Quarters > 2 > balance Sheet > property Plant Equipment
511043
Quarters > 2 > balance Sheet > total Assets
14903740
Quarters > 2 > balance Sheet > payables
3234462
Quarters > 2 > balance Sheet > short Term Debt
1250
Quarters > 2 > balance Sheet > long Term Debt
2299600
Quarters > 2 > balance Sheet > total Liabilities
8135980
Quarters > 2 > balance Sheet > equity
6767750
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
54360
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
1144040
Quarters > 2 > cash Flow > cash From Operations
926430
Quarters > 2 > cash Flow > capital Expenditures
938500
Quarters > 2 > cash Flow > cash From Investing
-527670
Quarters > 2 > cash Flow > cash From Financing
813070
Quarters > 2 > cash Flow > net Change In Cash
1211830
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.004605716627649203
Quarters > 2 > ratios > PB
8.899351483136936
Quarters > 2 > ratios > ROE
1.095932917143807
Quarters > 2 > ratios > ROA
0.4976603188193031
Quarters > 2 > ratios > FCF
-12070
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
-0.0038069464945813306
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
16114656
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
1013097
Quarters > 3 > balance Sheet > short Term Investments
94
Quarters > 3 > balance Sheet > receivables
10295417
Quarters > 3 > balance Sheet > inventories
665281
Quarters > 3 > balance Sheet > total Current Assets
11985888
Quarters > 3 > balance Sheet > property Plant Equipment
826940
Quarters > 3 > balance Sheet > total Assets
15408483
Quarters > 3 > balance Sheet > payables
4387872
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
3022768
Quarters > 3 > balance Sheet > total Liabilities
8654230
Quarters > 3 > balance Sheet > equity
6754253
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
611528
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
8.923090893989313
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
5330360
Annuals > 0 > income Statement > cost Of Revenue
494245
Annuals > 0 > income Statement > gross Profit
4836117
Annuals > 0 > income Statement > operating Expenses
5814558
Annuals > 0 > income Statement > operating Income
-431140
Annuals > 0 > income Statement > interest Expense
72844
Annuals > 0 > income Statement > pretax Income
-436980
Annuals > 0 > income Statement > net Income
285170
Annuals > 0 > income Statement > eps
0.01770388490916554
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
16107764
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-8.088384274232885
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
468781
Annuals > 0 > balance Sheet > short Term Investments
60541
Annuals > 0 > balance Sheet > receivables
3232112
Annuals > 0 > balance Sheet > inventories
699415
Annuals > 0 > balance Sheet > total Current Assets
8427233
Annuals > 0 > balance Sheet > property Plant Equipment
463379
Annuals > 0 > balance Sheet > total Assets
11809795
Annuals > 0 > balance Sheet > payables
1402295
Annuals > 0 > balance Sheet > short Term Debt
630
Annuals > 0 > balance Sheet > long Term Debt
2552519
Annuals > 0 > balance Sheet > total Liabilities
4323144
Annuals > 0 > balance Sheet > equity
7486651
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
285170
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.01770388490916554
Annuals > 0 > ratios > PB
6.7558082993317035
Annuals > 0 > ratios > ROE
3.8090462611386586
Annuals > 0 > ratios > ROA
2.414690517489931
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
5612830
Annuals > 1 > income Statement > cost Of Revenue
734534
Annuals > 1 > income Statement > gross Profit
4878292
Annuals > 1 > income Statement > operating Expenses
6269913
Annuals > 1 > income Statement > operating Income
-616650
Annuals > 1 > income Statement > interest Expense
54117
Annuals > 1 > income Statement > pretax Income
-623850
Annuals > 1 > income Statement > net Income
54360
Annuals > 1 > income Statement > eps
0.003373484166220675
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
16113904
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-10.98643643224541
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2224930
Annuals > 1 > balance Sheet > short Term Investments
94
Annuals > 1 > balance Sheet > receivables
3971610
Annuals > 1 > balance Sheet > inventories
707377
Annuals > 1 > balance Sheet > total Current Assets
11609063
Annuals > 1 > balance Sheet > property Plant Equipment
511043
Annuals > 1 > balance Sheet > total Assets
14903735
Annuals > 1 > balance Sheet > payables
3234462
Annuals > 1 > balance Sheet > short Term Debt
1250
Annuals > 1 > balance Sheet > long Term Debt
2299602
Annuals > 1 > balance Sheet > total Liabilities
8135982
Annuals > 1 > balance Sheet > equity
6767753
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
54360
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
1144040
Annuals > 1 > cash Flow > cash From Operations
926430
Annuals > 1 > cash Flow > capital Expenditures
938500
Annuals > 1 > cash Flow > cash From Investing
-527670
Annuals > 1 > cash Flow > cash From Financing
813070
Annuals > 1 > cash Flow > net Change In Cash
1211830
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
0.003373484166220675
Annuals > 1 > ratios > PB
7.476286229713171
Annuals > 1 > ratios > ROE
0.8032208031232819
Annuals > 1 > ratios > ROA
0.3647407847764335
Annuals > 1 > ratios > FCF
-12070
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.002150430353315529
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
8748516
Annuals > 2 > income Statement > cost Of Revenue
426696
Annuals > 2 > income Statement > gross Profit
8321820
Annuals > 2 > income Statement > operating Expenses
8689235
Annuals > 2 > income Statement > operating Income
59281
Annuals > 2 > income Statement > interest Expense
12820
Annuals > 2 > income Statement > pretax Income
490525
Annuals > 2 > income Statement > net Income
1105677
Annuals > 2 > income Statement > eps
0.06861313080465385
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
16114656
Annuals > 2 > income Statement > income Tax Expense
-615152
Annuals > 2 > income Statement > EBITDA
1064092
Annuals > 2 > income Statement > operating Margin
0.6776120658635133
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
1013097
Annuals > 2 > balance Sheet > short Term Investments
94
Annuals > 2 > balance Sheet > receivables
3935080
Annuals > 2 > balance Sheet > inventories
665281
Annuals > 2 > balance Sheet > total Current Assets
11985888
Annuals > 2 > balance Sheet > property Plant Equipment
826940
Annuals > 2 > balance Sheet > total Assets
15408483
Annuals > 2 > balance Sheet > payables
4387872
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
3022768
Annuals > 2 > balance Sheet > total Liabilities
8654230
Annuals > 2 > balance Sheet > equity
6754253
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
1105680
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-3048700
Annuals > 2 > cash Flow > cash From Operations
-54250
Annuals > 2 > cash Flow > capital Expenditures
1836570
Annuals > 2 > cash Flow > cash From Investing
-1492030
Annuals > 2 > cash Flow > cash From Financing
-142750
Annuals > 2 > cash Flow > net Change In Cash
-1689030
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.06861313080465385
Annuals > 2 > ratios > PB
7.491578985862685
Annuals > 2 > ratios > ROE
16.37008563345199
Annuals > 2 > ratios > ROA
7.175768049327114
Annuals > 2 > ratios > FCF
-1890820
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.21613036999646568
Annuals > 2 > health Score
51
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
101640
Annuals > 3 > income Statement > gross Profit
-101640
Annuals > 3 > income Statement > operating Expenses
102624
Annuals > 3 > income Statement > operating Income
-102530
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
295960
Annuals > 3 > income Statement > net Income
257870
Annuals > 3 > income Statement > eps
0.1285185997368526
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2006480
Annuals > 3 > income Statement > income Tax Expense
38086
Annuals > 3 > income Statement > EBITDA
-102624
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
2702442
Annuals > 3 > balance Sheet > short Term Investments
90
Annuals > 3 > balance Sheet > receivables
10827
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2713363
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
2713360
Annuals > 3 > balance Sheet > payables
55863
Annuals > 3 > balance Sheet > short Term Debt
310
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
94260
Annuals > 3 > balance Sheet > equity
2619100
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
257868
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
83910
Annuals > 3 > cash Flow > cash From Operations
-56693
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
400000
Annuals > 3 > cash Flow > cash From Financing
0
Annuals > 3 > cash Flow > net Change In Cash
343307
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.1285185997368526
Annuals > 3 > ratios > PB
2.4055390019472336
Annuals > 3 > ratios > ROE
9.845748539574663
Annuals > 3 > ratios > ROA
9.50371495120441
Annuals > 3 > ratios > FCF
-56693
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
66
Valuation > metrics > PE
103.3333
Valuation > metrics > PB
8.039792323669465
Valuation > final Score
1
Valuation > verdict
240.7% Overvalued
Profitability > metrics > ROE
2.3333533689968142
Profitability > metrics > ROA
2.072923131325477
Profitability > metrics > Net Margin
0.06721224433261
Profitability > final Score
21
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.577446521474892
Risk > final Score
68
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.006899869914642
Liquidity > metrics > Quick Ratio
5.508355756722562
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
13
Prev Profitabilities > 1
8
Prev Profitabilities > 2
50
Prev Risks > 0
68
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:08:25.496Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-01
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-06
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-18
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-02
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.06
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.06
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-05-20
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-07-30
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
1.19
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
1.19
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-04-23
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.21
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.21
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-10
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.15
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.15
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-06-23
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.13
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.13
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-09-30
Earnings History > 9 > report Date
2019-10-18
Earnings History > 9 > date
2019-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.12
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.12
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-05-03
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
6.47
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
6.47
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-10-11
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.57
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.57
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-05-18
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.71
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.71
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-06-30
Earnings History > 13 > report Date
2017-09-25
Earnings History > 13 > date
2017-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.81
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.81
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-03-31
Earnings History > 14 > report Date
2017-04-13
Earnings History > 14 > date
2017-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-1.11
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-1.11
Earnings History > 14 > surprise Percent
-
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhy ABLD stock appeals to dividend investors - 2025 Fundamental Recap & Low Risk Entry Point Guides bollywoodhelpline.com
Read more →(Last Updated 2024-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of AbL Diagnostics SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2024-12-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.